Georgian biotech company to increase bacteriophage production capacity by 300% with EU, FAO $150,000 grant
The matching grant is a part of a total $1 million investment raised by the company aimed to allow for a 300% increase in PowerPhage’s production capacity. Photo: Biochimpharm.
Tweet 
Share
A Georgian company producing bacteriophages, Biochimpharm, has received a grant of $150,000 from the EU and FAO to support PowerPhage production, a natural, bacteriophage antimicrobial veterinary solution which reduces the use of antibiotics in meat production with a focus on poultry farms, announces the EU Delegation to Georgia.
????EU & @FAO support Biochimpharm, a Georgian biotech company known worldwide for producing bacteriophages – a sustainable alternative to antibiotics.
— EU Delegation Georgia ???????? (@EUinGeorgia) May 28, 2021
????https://t.co/a9bPyvID1S#EU4Georgia #EU4Business pic.twitter.com/2DDHLFWRJQ
The matching grant is a part of a total $1 million investment raised by the company aimed to allow for a 300% increase in PowerPhage’s production capacity.
The investment is mainly destined to upgrade the manufacturing line and to ensure EU good manufacturing practice compliance.
The widespread use of antibiotics in poultry farms increases health risks for consumers. Biochimpharm’s innovative products provide a Georgian-made alternative to veterinary antibiotics. With EU and FAO support, the company will be able to further develop its product, increase production and meet EU standards", said Dominik Papenheim, Team Leader for Economic Development and Market Opportunities at the Delegation of the EU to Georgia.
Biochimpharm has over 80 years of experience in research, development and the production of bacteriophages. The company is ISO 9001-2015 certified, holds 12 registered products and two international patents under its name.
The company currently exports its products to eight countries outside Georgia and is a legally authorised pharmaceutical manufacturer.
Georgia has started exporting white flower bulbs to several countries of the EU and especially to Holland after the National Environment Agency issued a license to use white flower bulbs for a period of three years, announces the agency.
The European Union pledges full support for boosting ferry traffic between Georgian-Bulgarian-Romanian and Ukrainian ports, says Georgian Economy Minister Natia Turnava.
Following the call for expression of interest 'Promoting European business and economic interests in Georgia', the EU announces that the European Business Association Georgia (EBA Georgia) is the organisation that submitted the winning project.
The European Union has allowed the importation of pet food from Georgia to the EU.
Georgia has reported 986 new cases of Covid-19 after conducting a total of 43,286 tests over the last 24 hours. Out of the 986 new cases 535 were reported in the Georgian capital of Tbilisi.
Georgia has reported 360 new cases of coronavirus, 1,195 recoveries and 16 deaths in the past 24 hours.
Georgia has joined the World Antimicrobial Awareness Week (WAAW) which is celebrated annually on November 18-24 and aims to increase awareness of global antimicrobial resistance and to avoid the spread of drug-resistant infections.
Georgia’s Economy Minister Levan Davitashvili on Tuesday noted the country’s “long tradition” in production of bacteriophages and its position on the world map of biotechnologies, after a Georgian-based biopharmaceutical company said it had completed a modernisation enabling it to make bacteriophages available for “millions of patients across the globe”.